Friday, 23 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
Fosun Pharma's LBP-ShC4 Receives FDA Approval for Androgenic Alopecia Study
CompanyDrug

Fosun Pharma’s LBP-ShC4 Receives FDA Approval for Androgenic Alopecia Study

May 12, 2025
MicroPort's Talos Stent Gains Marketing Approval in Argentina
CompanyMedical Device

MicroPort’s Talos Stent Gains Marketing Approval in Argentina

May 12, 2025
Hainan Unveils 20 Measures to Boost Pharmaceutical Industry Reform and Quality
Policy / Regulatory

Hainan Unveils 20 Measures to Boost Pharmaceutical Industry Reform and Quality

May 12, 2025
Minghui Pharmaceutical Signs Licensing Deal with Qilu for B7-H3 ADC Development
CompanyDeals

Minghui Pharmaceutical Signs Licensing Deal with Qilu for B7-H3 ADC Development

May 12, 2025
EnChannel Medical Secures RMB 600 Million in Series B Funding for Electrophysiological Products
CompanyDeals

EnChannel Medical Secures RMB 600 Million in Series B Funding for Electrophysiological Products

May 12, 2025
Hansoh Pharma's Ameile Wins Fourth NMPA Approval for NSCLC Treatment
CompanyDrug

Hansoh Pharma’s Ameile Wins Fourth NMPA Approval for NSCLC Treatment

May 12, 2025
Eli Lilly and Purdue Expand Partnership With $250 Million Investment
CompanyDeals

Eli Lilly and Purdue Expand Partnership With $250 Million Investment

May 12, 2025
CARsgen Therapeutics' CT0596 Shows Promising Results in Early Clinical Study
CompanyDrug

CARsgen Therapeutics’ CT0596 Shows Promising Results in Early Clinical Study

May 12, 2025
CSPC Receives FDA Approval for SYH2046 in Heart Failure After Acute Myocardial Infarction
CompanyDrug

CSPC Receives FDA Approval for SYH2046 in Heart Failure After Acute Myocardial Infarction

May 12, 2025
UCB Gets Japanese Approval for New Administration Routes of Rystiggo in gMG
CompanyDrug

UCB Gets Japanese Approval for New Administration Routes of Rystiggo in gMG

May 12, 2025
Shanghai Escugen Partners with ConjugateBio on EZWi-Fit Platform for ADC Development
CompanyDeals

Shanghai Escugen Partners with ConjugateBio on EZWi-Fit Platform for ADC Development

May 12, 2025
InnoCare Pharma's Mesutoclax Granted Breakthrough Therapy Designation for R/R MCL
CompanyDrug

InnoCare Pharma’s Mesutoclax Granted Breakthrough Therapy Designation for R/R MCL

May 12, 2025
1 2 … 168 169 170 171 172 … 289 290
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up